Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125832001 | 12583200 | 1 | I | 20160708 | 20160720 | 20160722 | 20160722 | EXP | GB-MHRA-EYC 00142443 | GB-GLAXOSMITHKLINE-GB2016103928 | GLAXOSMITHKLINE | 40.00 | YR | F | Y | 82.55000 | KG | 20160722 | CN | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125832001 | 12583200 | 1 | I | CHLORHEXIDINE GLUCONATE. | CHLORHEXIDINE GLUCONATE | 1 | Oral | 10 ML, BID | 20 | ML | Y | 1066LE0106 | 0 | 10 | ML | BID | |||
125832001 | 12583200 | 2 | I | Cyclizine | CYCLIZINE | 1 | Intramuscular | UNK | U | 0 | |||||||||
125832001 | 12583200 | 3 | I | Dihydrocodeine tartrate | DIHYDROCODEINE BITARTRATE | 1 | Unknown | UNK | U | 0 | |||||||||
125832001 | 12583200 | 4 | I | LORATADINE. | LORATADINE | 1 | Unknown | UNK | U | 0 | |||||||||
125832001 | 12583200 | 5 | I | Oramorph | MORPHINE SULFATE | 1 | Unknown | UNK | U | 0 | |||||||||
125832001 | 12583200 | 6 | I | PREDNISOLONE. | PREDNISOLONE | 1 | Unknown | UNK | U | 0 | |||||||||
125832001 | 12583200 | 7 | PS | Salbutamol | ALBUTEROL | 1 | Respiratory (inhalation) | UNK | U | 20983 | NEBULISER SOLUTION | ||||||||
125832001 | 12583200 | 8 | I | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | Respiratory (inhalation) | UNK | U | 0 | |||||||||
125832001 | 12583200 | 9 | I | LYRICA | PREGABALIN | 1 | Unknown | 150MG AND 300MG | U | 0 | |||||||||
125832001 | 12583200 | 10 | C | ADCAL-D3 | CALCIUM CARBONATECHOLECALCIFEROL | 1 | UNK | U | 0 | ||||||||||
125832001 | 12583200 | 11 | C | ALENDRONIC ACID | ALENDRONIC ACID | 1 | UNK | U | 0 | ||||||||||
125832001 | 12583200 | 12 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | UNK | U | 0 | ||||||||||
125832001 | 12583200 | 13 | C | COSMOCOL | 2 | UNK | U | 0 | |||||||||||
125832001 | 12583200 | 14 | C | LACTULOSE. | LACTULOSE | 1 | UNK | U | 0 | ||||||||||
125832001 | 12583200 | 15 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | UNK | U | 0 | ||||||||||
125832001 | 12583200 | 16 | C | PHENOXYMETHYLPENICILLIN | PENICILLIN V | 1 | UNK | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125832001 | 12583200 | 1 | Mouth ulceration |
125832001 | 12583200 | 2 | Product used for unknown indication |
125832001 | 12583200 | 3 | Product used for unknown indication |
125832001 | 12583200 | 4 | Product used for unknown indication |
125832001 | 12583200 | 5 | Product used for unknown indication |
125832001 | 12583200 | 6 | Product used for unknown indication |
125832001 | 12583200 | 7 | Product used for unknown indication |
125832001 | 12583200 | 8 | Product used for unknown indication |
125832001 | 12583200 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125832001 | 12583200 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125832001 | 12583200 | Asthma | |
125832001 | 12583200 | Drug interaction | |
125832001 | 12583200 | Feeling abnormal | |
125832001 | 12583200 | Feeling drunk | |
125832001 | 12583200 | Oral discomfort | |
125832001 | 12583200 | Oxygen saturation decreased | |
125832001 | 12583200 | Swelling face |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125832001 | 12583200 | 1 | 20160708 | 20160708 | 0 |